Elixir Clinical Research
PrivateLast Round
Series A
Apr 22, 2022
Total Funding Raised
$52M
Company Overview
Elixir Clinical Research operates in Healthcare & Life Sciences and is based in Shanghai. Its latest recorded funding round was a Series A round in April 2022.
Elixir Clinical Research is a biotechnology company that provides technology-driven, full-service clinical research organization (CRO) services to pharmaceutical and medical enterprises.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Biotechnology, Compliance
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Elixir Clinical Research Comparables
Compare Elixir Clinical Research with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Harvest Integrated Research Organization | 93% | |
| ClinChoice | 84% | |
| LSK Global Pharma Services Co., Ltd. | 82% |
For institutional investors. Book with your work email.
Elixir Clinical Research Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Elixir Clinical Research Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LYFE Capital | Series A |
| Sinovation Ventures | Series A |
Elixir Clinical Research Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Elixir Clinical Research's valuation, stock price, and market status.
Is Elixir Clinical Research a public or private company?
Elixir Clinical Research is a private company.
What is the current stock price of Elixir Clinical Research?
Elixir Clinical Research is a private company, so its shares have no public market price. Caplight tracks Elixir Clinical Research's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Elixir Clinical Research worth (valuation)?
Valuation information for Elixir Clinical Research is not publicly available.
Can I buy Elixir Clinical Research stock?
Elixir Clinical Research shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Elixir Clinical Research's last funding round?
Elixir Clinical Research's most recent funding round was Series A on April 22, 2022.
Who are the main investors in Elixir Clinical Research?
Key investors in Elixir Clinical Research include LYFE Capital, Sinovation Ventures.
Will Elixir Clinical Research IPO soon?
No public IPO plans have been announced for Elixir Clinical Research.
How can I track Elixir Clinical Research secondary market activity?
Caplight tracks bids, offers, and trades in Elixir Clinical Research's shares on secondary markets.